Traumatic Brain Injury (TBI)
From single severe head injury through cumulative subconcussive load to late-stage post-concussive syndrome.
Concussion that never quite cleared. Persistent post-concussive symptoms — sleep disruption, cognitive fog, emotional dysregulation, headache — that conventional follow-up has run out of moves on. Or the cumulative load of years of subconcussive hits. Each one represents a brain whose repair signaling has stalled at a level conventional care does not address.
Best-fit candidacy
Best candidates have documented injury history, lingering symptoms beyond expected recovery windows, and have had at least a baseline neurological workup. Prior imaging is reviewed during the Diagnostic Process and supplemented by our own Comprehensive Brain MRI and Brain PET Scan as indicated.
Substance-Induced Brain Injury
Brain dysfunction following alcohol or stimulant use, post-acute withdrawal cognitive impairment, addiction-related cognitive decline.
Alcohol use disorder, methamphetamine and stimulant exposure, and the cognitive aftermath of severe substance use can leave a brain in a state that traditional rehab does not address. When patients want a brain-first approach to recovery rather than a behavior-only one, the regenerative pillar of our practice is built into that conversation. Integrated with the Rescue From Rehab framework when behavioral recovery is also part of the picture.
Best-fit candidacy
Patients in sustained recovery or seeking a brain-first recovery approach. Active use is not a contraindication but is evaluated case-by-case with realistic expectations.
Post-COVID Neurological Symptoms
Long-COVID brain fog, executive dysfunction, fatigue, autonomic instability, and post-viral neurological presentations.
Post-COVID neurology is where the literature on neural exosomes is moving fastest. The clinical picture is heterogeneous: persistent brain fog, executive dysfunction, anosmia that did not return, autonomic dysregulation, post-exertional malaise. What unites the cases we work with is a clinical timeline anchored to the viral illness and a neuroinflammatory signature on Foundation Labs.
Best-fit candidacy
Patients with a documented or strongly inferred COVID timeline, persistent neurological symptoms past 12 weeks, and willingness to enter a workup-first approach are the best fit.
Post-Stroke Recovery
Ischemic and hemorrhagic stroke survivors whose recovery has plateaued under conventional rehab.
Standard post-stroke rehabilitation captures most of the recoverable function in the first 3–6 months. After that, conventional medicine has few additional moves. Patients whose deficits have plateaued, but who still have measurable inflammation, autonomic instability, or residual cognitive symptoms that the imaging does not fully explain, sometimes have room for additional support.
Best-fit candidacy
Stroke patients past the acute and subacute phases, medically stable, with a clear residual deficit pattern. Coordination with the existing neurology and rehab team is mandatory.
Early-Stage Neurodegeneration
Mild cognitive impairment, early Alzheimer’s presentation, early Parkinson’s disease, prodromal disease states.
The window for meaningful intervention in neurodegeneration is widest at the earliest stages. Patients who have been told the diagnosis is mild, or who have been told to wait and see, often want a workup that takes the situation seriously now rather than later. We are honest that this work does not reverse advanced disease and we set expectations accordingly.
Best-fit candidacy
Early MCI, early Alzheimer’s, early Parkinson’s, or strong prodromal signals. Patients with advanced disease are evaluated individually but expectations are scaled to what realistic intervention can do at that stage.
Neuroinflammatory Conditions
Relapsing-remitting MS, autoimmune neurological inflammation, arachnoiditis, fibromyalgia with neurological features.
Multiple sclerosis, autoimmune inflammatory neurological disease, arachnoiditis, and fibromyalgia with strong neurological features are conditions where regenerative support is considered as adjunct to standard care. We do not displace disease-modifying therapy for MS. We do not replace anti-inflammatory or pain management work that is already helping. We add a regenerative dimension when the workup supports it.
Best-fit candidacy
Stable on existing therapy, current neurologist in the loop, and a presenting picture that includes neuroinflammatory or post-inflammatory residual symptoms.
Peripheral Neuropathy
Diabetic, idiopathic, chemotherapy-induced, and post-viral peripheral neuropathies.
Peripheral neuropathy is where the cellular and matrix support story has some of its strongest clinical traction. Nerve tissue does not regenerate the way other tissue does, and supportive interventions are about creating the environment in which the body’s own repair signaling has the best chance to work. We evaluate symptom distribution, underlying drivers, and the dial that conventional therapy has already turned.
Best-fit candidacy
Documented neuropathy with identified or suspected driver, stable underlying condition (e.g., diabetes management in place), and openness to a workup-first approach.
Chronic Pain Syndromes
Complex regional pain syndrome, central sensitization, persistent post-concussive pain, and refractory chronic pain with neurological features.
Chronic pain is a brain problem before it is a tissue problem. Patients whose pain has outlived the original injury, who have been through the standard interventional sequence, or whose presentation has the markers of central sensitization, sometimes have a regenerative angle that orthopedic-only practices miss. The Diagnostic Process is the gate. Brain imaging is mandatory.
Best-fit candidacy
Pain that has been worked up neurologically, has documented imaging, and has not responded to standard interventional management. We do not enter cases where the basic workup has not been done.
Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS)
Post-viral and idiopathic ME/CFS, including long-COVID overlap presentations.
ME/CFS has been under-served by conventional medicine for decades. The clinical picture overlaps substantially with the long-COVID workup; the underlying neuroinflammatory and autonomic signatures are often where the regenerative angle becomes a candid conversation. We approach these cases with the assumption that the patient is right about what they are experiencing.
Best-fit candidacy
Established or suspected ME/CFS with neurological features, willingness to go through the Diagnostic Process (which often surfaces previously undiagnosed contributors), and realistic expectations about what supportive intervention can do.
Autism Spectrum Disorder
Children and adults on the spectrum where families want a neurological workup beyond behavioral services.
Autism is not something Cellular Rejuvenation Therapy treats. What we offer families is a neurological workup that takes seriously the inflammatory, GI-brain axis, and neurogenomic dimensions that behavioral services rarely look at. Whether any regenerative protocol becomes appropriate is a careful candidacy decision made on the basis of what we find and what realistic adjunct support might look like.
Best-fit candidacy
Established ASD diagnosis, behavioral services in place, family interested in a neurological-level workup. We do not enter cases where regenerative therapy is being framed as a cure or as a replacement for behavioral and educational supports.
